Where do HIV-infected adolescents go after transfer? Tracking transition/transfer of HIV-infected adolescents using linkage of cohort data to a health information system platform

被引:46
作者
Davies, Mary-Ann [1 ]
Tsondai, Priscilla [1 ]
Tiffin, Nicki [1 ,2 ]
Eley, Brian [3 ,4 ]
Rabie, Helena [5 ]
Euvrard, Jonathan [1 ,6 ,7 ]
Orrell, Catherine [8 ,9 ]
Prozesky, Hans [10 ,11 ]
Wood, Robin [8 ,9 ]
Cogill, Dolphina [8 ,9 ]
Haas, Andreas D. [12 ]
Sohn, Annette H. [13 ]
Boulle, Andrew [1 ,3 ,4 ,6 ,7 ]
机构
[1] Univ Cape Town, Sch Publ Hlth & Family Med, CIDER, Cape Town, South Africa
[2] Hlth Impact Assessment Directorate, Western Cape Prov Dept Hlth, Cape Town, South Africa
[3] Univ Cape Town, Red Cross War Mem Childrens Hosp, Cape Town, South Africa
[4] Univ Cape Town, Dept Paediat & Child Hlth, Cape Town, South Africa
[5] Univ Stellenbosch, Tygerberg Acad Hosp, Dept Paediat & Child Hlth, Stellenbosch, South Africa
[6] Khayelitsha ART Programme, Cape Town, South Africa
[7] Med Sans Frontieres, Cape Town, South Africa
[8] Univ Cape Town, Gugulethu HIV Programme, Cape Town, South Africa
[9] Univ Cape Town, Desmond Tutu HIV Ctr, Cape Town, South Africa
[10] Univ Stellenbosch, Dept Med, Div Infect Dis, Cape Town, South Africa
[11] Tygerberg Acad Hosp, Cape Town, South Africa
[12] Univ Bern, ISPM, Bern, Switzerland
[13] TREAT Asia AmfAR, Bangkok, Thailand
关键词
HIV-1; adolescents; transfer; transition; sub-Saharan Africa; antiretroviral; data linkage; ANTIRETROVIRAL TREATMENT; SOUTH-AFRICA; TREATMENT OUTCOMES; ADULT CARE; CHILDREN; THERAPY; MORTALITY; INITIATION; PROGRAM; MODEL;
D O I
10.7448/IAS.20.4.21668
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction: To evaluate long-term outcomes in HIV-infected adolescents, it is important to identify ways of tracking outcomes after transfer to a different health facility. The Department of Health (DoH) in the Western Cape Province (WCP) of South Africa uses a single unique identifier for all patients across the health service platform. We examined adolescent outcomes after transfer by linking data from four International epidemiology Databases to Evaluate AIDS Southern Africa (IeDEA-SA) cohorts in the WCP with DoH data. Methods: We included adolescents on antiretroviral therapy who transferred out of their original cohort from 10 to 19 years of age between 2004 and 2014. The DoH conducted the linkage separately for each cohort and linked anonymized data were then combined. The primary outcome was successful transfer defined as having a patient record at a facility other than the original facility after the transfer date. Secondary outcomes included the proportion of patients retained, with HIV-RNA <400 copies/ml and CD4 >500 cells/mu l at 1, 2 and 3 years post-transfer. Results: Of 460 adolescents transferred out (53% female), 72% transferred at 10-14 years old, and 79% transferred out of tertiary facilities. Overall, 81% of patients transferred successfully at a median (interquartile range) of 56 (27-134) days following transfer date; 95% reached the transfer site <18 months after transfer out. Among those transferring successfully, the proportion retained decreased from 1 to 3 years post-transfer (90-84%). There was no significant difference between transfer and 1-3 years post-transfer in the proportion of retained adolescents with HIV-RNA <400 copies/ml and CD4 > 500 cells/mu l except for HIV-RNA <400 copies/ml at 3 years (86% vs. 75%; p = 0.007). The proportion virologically suppressed and with CD4 >500 cells/mu l was significantly lower at 1 and 2 years post-transfer in those transferring at 15-19 vs. 10-14 years of age. Using laboratory data alone over-estimated time to successful transfer. Conclusions: Linking cohort data to health information system data allowed efficient assessment of post-transfer outcomes. Although >80% of adolescents transferred successfully with nearly 85% of them retained for 3 years post-transfer, the decline in the proportion virologically suppressed and poorer outcomes in older adolescents are concerns.
引用
收藏
页数:9
相关论文
共 26 条
  • [1] [Anonymous], INT AIDS C DURB S AF
  • [2] [Anonymous], INT AIDS C DURB S AF
  • [3] [Anonymous], 2013, REV ANT TREATM GUID
  • [4] Arowosegbe O, 2016, INT WORKSH HIV PED D
  • [5] Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia
    Bolton-Moore, Carolyn
    Mubiana-Mbewe, Mwangelwa
    Cantrell, Ronald A.
    Chintu, Namwinga
    Stringer, Elizabeth M.
    Chi, Benjamin H.
    Sinkala, Moses
    Kankasa, Chipepo
    Wilson, Craig M.
    Wilfert, Catherine M.
    Mwango, Albert
    Levy, Jens
    Abrams, Elaine J.
    Bulterys, Marc
    Stringer, Jeffrey S. A.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (16): : 1888 - 1899
  • [6] Davies MA, 2009, SAMJ S AFR MED J, V99, P730
  • [7] Antiretroviral therapy for children: challenges and opportunities
    Eley, Brian
    Nuttall, James
    [J]. ANNALS OF TROPICAL PAEDIATRICS, 2007, 27 (01): : 1 - 10
  • [8] Evans D, 2013, AIDS RES HUM RETROV, V29, P892, DOI [10.1089/AID.2012.0215, 10.1089/aid.2012.0215]
  • [9] Temporal Trends in Baseline Characteristics and Treatment Outcomes of Children Starting Antiretroviral Treatment: An Analysis in Four Provinces in South Africa, 2004-2009
    Fatti, Geoffrey
    Bock, Peter
    Eley, Brian
    Mothibi, Eula
    Grimwood, Ashraf
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2011, 58 (03) : E60 - E67
  • [10] Mortality in perinatally HIV-infected young people in England following transition to adult care: an HIV Young Persons Network (HYPNet) audit
    Fish, R.
    Judd, A.
    Jungmann, E.
    O'Leary, C.
    Foster, C.
    [J]. HIV MEDICINE, 2014, 15 (04) : 239 - 244